The trademark DERMAVIVE was filed by UAS Pharmaceuticals Pty Ltd., a corporation established under the laws of the Commonwealth of Australia (the "Applicant"). The application was published for oppositions on August 17, 2020, and received one opposition filed on November 17, 2020 by Dabur India Limited on Art. 8(4). the opponent was represented by INGENIAS and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued November 17, 2020
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
Change of name and professional address of the trademark registration was recorded on September 8, 2021.
The Opposition with reference B 003135047 was rejected according to Article 8(4) EUTMR with decision issued on December 9, 2021 by the EUIPO.